NovoCure (NVCR) EBITDA Margin Growth (1y) (2015 - 2026)
NovoCure (NVCR) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 851.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 241.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -313.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | 1,913.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,913.00 |
| Mar 31, 2026 | -1,430.00 |
| Dec 31, 2025 | 1,609.00 |
| Sep 30, 2025 | -85.00 |
| Jun 30, 2025 | -255.00 |
| Mar 31, 2025 | 555.00 |
| Dec 31, 2024 | -60.00 |
| Sep 30, 2024 | 2,505.00 |
| Jun 30, 2024 | 2,738.00 |
| Mar 31, 2024 | 1,933.00 |
| Dec 31, 2023 | -519.00 |
| Sep 30, 2023 | -2,696.00 |
| Jun 30, 2023 | -3,471.00 |
| Mar 31, 2023 | -4,872.00 |
| Dec 31, 2022 | -1,590.00 |
| Sep 30, 2022 | -1,239.00 |
| Jun 30, 2022 | -579.00 |
| Mar 31, 2022 | -52.00 |
| Dec 31, 2021 | -2,596.00 |
| Sep 30, 2021 | -1,772.00 |